peptide poly-agonists

Boehringer Ingelheim, Gubra to develop anti-obesity peptide poly-agonists
Pharmaceutical Business Review
Thu, 05/30/19 - 10:05 am
obesity
peptide poly-agonists
Boehringer Ingelheim
Gubra